Tichenor Mark S, Boger Dale L
Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Nat Prod Rep. 2008 Apr;25(2):220-6. doi: 10.1039/b705665f. Epub 2007 Nov 6.
DNA-binding small molecules are an important source of anticancer therapeutics that display a diverse array of mechanisms of action. Synthetic studies on the new DNA-alkylating natural product yatakemycin, detailed in this Highlight, have served to reassign its structure, assign the absolute stereochemistry, and provide access to yatakemycin and a series of structural analogues for biological evaluation. Studies on the DNA alkylation properties of (+)-and ent-(-)-yatakemycin and related analogues have demonstrated the enhanced DNA alkylation properties of this class of agents and provided insight into their interaction with DNA.
DNA结合小分子是抗癌治疗药物的重要来源,其作用机制多种多样。本综述详细介绍了对新型DNA烷基化天然产物紫杉醇的合成研究,这些研究重新确定了其结构,确定了绝对立体化学,并提供了获得紫杉醇及其一系列结构类似物用于生物学评估的途径。对(+)-和对映体(-)-紫杉醇及相关类似物的DNA烷基化性质的研究表明了这类药物增强的DNA烷基化性质,并深入了解了它们与DNA的相互作用。